Filter

691 - 700 of 2,175 Results

  • COVID-19 preventable mortality

    Issue Brief

    This updated analysis estimates that nationally at least 234,000 deaths from COVID-19 between June 2021 and March 2022 could have been prevented with a primary series of vaccinations. These vaccine-preventable deaths represent 60% of all adult COVID-19 deaths since June 2021, when vaccines first became widely available.

  • Help with Medicare Premium and Cost-Sharing Assistance Varies by State

    Issue Brief

    This data note provides an overview of programs that help beneficiaries with modest incomes with their Medicare costs, including the Medicare Savings Programs and the Part D Low-Income Subsidy, and highlights findings from corresponding state-level profiles of eligibility and enrollment.

  • Nursing Facility Staffing Shortages During the COVID-19 Pandemic

    Issue Brief

    This data note presents the most recent national and state-level data on nursing facility-reported staff shortages and describes the Biden Administration’s new policy initiatives to address staffing and other quality issues in nursing facilities.

  • Medicaid Spending and Enrollment: Updated for FY 2022 and Looking Ahead to FY 2023

    Issue Brief

    In February 2022, the Kaiser Family Foundation (KFF) and Health Management Associates (HMA) fielded a rapid, mini-survey of Medicaid directors in all 50 states and the District of Columbia as a follow-up to the annual Medicaid Budget Survey conducted in summer 2021. This brief explores Medicaid enrollment and spending growth estimates for FY 2022 and projections for FY 2023, as reported by state Medicaid directors.

  • Are There Enough COVID-19 Vaccines for America Without More Funding?

    Issue Brief

    This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.

  • Out-of-pocket spending on insulin among people with private insurance

    Issue Brief

    This analysis of insurance claims data finds that Congressional proposals to set a $35 per month cap on what people pay out of pocket for insulin would provide financial relief to at least 1 out of 5 insulin users with different types of private health insurance.